{"id":386070,"title":"Communication et transparence : Médicaments contre la COVID-19 exigences relatives aux autorisations de mise en marché - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"fr","captureDate":"2026-04-13","captureTimestamp":"2026-04-13T10:24:56.552000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/lignes-directrices-autorisations-mise-marche-medicaments/communication-transparence.html","snippet":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des médicaments contre la COVID-19 : Communication et transparence Aperçu Présentations en continu et examens Exigences non cliniques et cliniques Exigences de qualité et de fabrication Exigences…","rawSnapshotUrl":"/api/snapshots/raw/386070","browseUrl":"https://replay.healtharchive.ca/job-6/20260413102456/https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/lignes-directrices-autorisations-mise-marche-medicaments/communication-transparence.html#ha_snapshot=386070","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}